A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices
Tài liệu tham khảo
http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf (12.4.2016)
Berger, 2010
Blonde, 2004, Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study, Curr. Med. Res. Opin., 20, 565, 10.1185/030079904125003278
Boone, 2012, Improved signal-to-noise ratio in laboratory-based phase contrast tomography, Microsc. Microanal., 18, 399, 10.1017/S1431927611012529
Brabant, 2011, Three-dimensional analysis of high-resolution X-ray computed tomography data with Morpho+, Microsc. Microanal., 17, 252, 10.1017/S1431927610094389
Campbell, 1996, Metformin: a new oral biguanide, Clin. Ther., 18, 360, 10.1016/S0149-2918(96)80017-8
Claeys, 2014, Release characteristics of polyurethanes tablets containing dicarboxylic acids as release modifiers – a case study with diprophylline, Int. J. Pharm., 477, 244, 10.1016/j.ijpharm.2014.10.046
Davis, 1986, Transit of pharmaceutical dosage forms through the small intestine, Gut, 27, 886, 10.1136/gut.27.8.886
Davis, 2009, Scintigraphic study to investigate the effect of food on a HPMC modified release formulation of UK-294,315, J. Pharm. Sci., 98, 1568, 10.1002/jps.21507
Desai, 2014, Surfactant-mediated dissolution of metformin hydrochloride tablets: wetting effects versus ion pairs diffusivity, J. Pharm. Sci., 103, 920, 10.1002/jps.23852
Gabrielsson, 2000
Gusler, 2001, Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers, J. Clin. Pharmacol., 41, 655, 10.1177/00912700122010546
Jabbour, 2011, Advantages of extended-release metformin in patients with type 2 diabetes mellitus, Postgrad. Med., 123, 15, 10.3810/pgm.2011.01.2241
Jansen, 1993, Bacterial adherence to hydrophilic polymer-coated polyurethanes stents, Gastrointest. Endosc., 39, 670, 10.1016/S0016-5107(93)70220-5
Klančar, 2015, Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high dose BCS class I model drug: in vitro and in vivo studies, AAPS Pharm. SciTech., 16, 398, 10.1208/s12249-014-0234-4
Lalloo, 2012, Decoupling the role of image size and calorie intake on gastric retention of swelling-based gastric retentive formulations: pre-screening in the dog model, Int. J. Pharm., 431, 90, 10.1016/j.ijpharm.2012.04.044
Liu, 2001, Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot melt extrusion, Eur. J. Pharm. Biopharm., 52, 181, 10.1016/S0939-6411(01)00162-X
Meier, 1974, Pharmacokinetic criteria for the evaluation of retard formulations, Eur. J. Clin. Pharmacol., 7, 429, 10.1007/BF00560355
Minagawa, 1976, The influence of titanium dioxide on the rheological and extrusion properties of polymer melts, J. Appl. Polym. Sci., 20, 501, 10.1002/app.1976.070200222
Paganin, 2002, Simultaneous phase and amplitude extraction from a single defocused image of a homogeneous object, J. Microsc., 206, 33, 10.1046/j.1365-2818.2002.01010.x
Rubbens, 2015, Intraluminal ethanol concentrations in humans after intake of alcoholic beverages, Eur. J. Pharm. Sci., 86, 91, 10.1016/j.ejps.2016.02.009
Tucker, 1981, Metformin kinetics in healthy subjects and in patients with diabetes mellitus, Br. J. Clin. Pharmacol., 12, 235, 10.1111/j.1365-2125.1981.tb01206.x
2003
Verhoeven, 2009, Modeling drug release from hot-melt extruded mini-matrices with constant and non-constant diffusivities, Eur. J. Pharm. Biopharm., 73, 292, 10.1016/j.ejpb.2009.06.010